Monoclonal Antibody Therapy Market by Type (Human mAb, Chimeric mAb, Humanized mAb and Murine mAb), by Disease Area (Cancer, Autoimmune Diseases, Inflammatory Diseases and Infectious Diseases), by Production Type (In Vitro and In Vivo), by End-user (Hospitals, Research Clinics and Others) - Global Outlook & Forecast 2022-2030

GR - 432716 Category: Pharmaceuticals
Monoclonal Antibody Therapy Market by Type (Human mAb, Chimeric mAb, Humanized mAb and Murine mAb), by Disease Area (Cancer, Autoimmune Diseases, Inflammatory Diseases and Infectious Diseases), by Production Type (In Vitro and In Vivo), by End-user (Hospitals, Research Clinics and Others) - Global Outlook & Forecast 2022-2030

Number of pages: 100-120  |  Report Format: PDF  |  Published date: 22 July, 2022

Historical Years – 2018 & 2019  |  Base Year – 2020  |  Forecasted Years – 2021 to 2031



Single User License
Single User License
Five Users License
Enterprise User License
Data Pack License
$4,750.00

Growth+Reports can now be customized as per client’s needs through GRG Health’s primary research and knowledge services capabilities

GRG Health’s unique GrowthMIX approach and robust research methodology helps us deliver unique & meaningful insights to our clients and uncover trends that won’t meet the standard approach